Department of Herbal Pharmaceutical Engineering, College of Herbal Bio-Industry, Daegu Haany University, Gyeongsan, Korea.
J Thromb Haemost. 2010 May;8(5):1107-15. doi: 10.1111/j.1538-7836.2010.03812.x. Epub 2010 Feb 17.
Activated protein C (APC) in complex with endothelial protein C receptor (EPCR) can reverse the barrier-disruptive and cytotoxic effects of proinflammatory cytokines by cleaving protease-activated receptor 1 (PAR-1). Recently, it was reported that the PAR-1-dependent vascular barrier-protective effect of APC is mediated through transactivation of the angiopoietin (Ang)-Tie2 signaling pathway. The antagonist of this pathway, Ang2, is stored in Weibel-Palade bodies within endothelial cells.
To determine whether the occupancy of EPCR by its ligand can switch the PAR-1-dependent signaling specificity of thrombin through the Ang-Tie2 axis.
We activated endothelial cells with thrombin before and after treating them with the catalytically inactive Ser195-->Ala substitution mutant of protein C. The expression levels of Ang1, Ang2 and Tie2 in response to thrombin were measured by both an enzyme-linked immunosorbent assay and a cell permeability assay in the absence and presence of small interfering RNA and a blocking antibody to Tie2.
Thrombin upregulated the expression of both Ang1 and Tie2 but downregulated the expression of Ang2 when EPCR was occupied by its ligand. The Ang1-Tie2-dependent protective effect of thrombin was initiated through protein C inhibiting the rapid mobilization of Ang2 from Weibel-Palade bodies. Interestingly, the protein C mutant also inhibited the thrombin mobilization of P-selectin.
These results suggest a physiologic role for the low concentration of thrombin in maintaining the integrity of the EPCR-containing vasculature through the PAR-1-dependent inhibition of Ang2 and P-selectin release from Weibel-Palade bodies.
激活蛋白 C(APC)与内皮蛋白 C 受体(EPCR)形成复合物,可以通过切割蛋白酶激活受体 1(PAR-1)逆转促炎细胞因子的屏障破坏和细胞毒性作用。最近有报道称,APC 通过 PAR-1 依赖性血管屏障保护作用是通过血管生成素(Ang)-Tie2 信号通路的转激活介导的。该通路的拮抗剂 Ang2 储存在内皮细胞的 Weibel-Palade 小体中。
确定 EPCR 配体的占据是否可以通过 Ang-Tie2 轴改变凝血酶的 PAR-1 依赖性信号特异性。
在使用蛋白 C 的催化失活 Ser195-->Ala 取代突变体处理内皮细胞之前和之后,用凝血酶激活内皮细胞。通过酶联免疫吸附试验和细胞通透性试验,在不存在和存在小干扰 RNA 和 Tie2 阻断抗体的情况下,测量 Ang1、Ang2 和 Tie2 的表达水平,以响应凝血酶。
当 EPCR 被其配体占据时,凝血酶上调了 Ang1 和 Tie2 的表达,但下调了 Ang2 的表达。通过蛋白 C 抑制 Ang2 从 Weibel-Palade 小体的快速动员,启动了凝血酶的 Ang1-Tie2 依赖性保护作用。有趣的是,蛋白 C 突变体也抑制了凝血酶动员 P-选择素。
这些结果表明,低浓度的凝血酶在通过 PAR-1 依赖性抑制 Ang2 和 P-选择素从 Weibel-Palade 小体释放来维持含有 EPCR 的脉管系统完整性方面具有生理作用。